Vanguard Specialized Funds · net assets $38.2B · 97 holdings as of July 31, 2026. Monthly N-PORT disclosure: the full book, not just equities.
EC: 97.7% · RA: 2.2% · STIV: 0.1%
| Month 1 | Month 2 | Month 3 | |
|---|---|---|---|
| Sales | $213M | $45.1M | $47M |
| Reinvestment | $1.04K | $156 | $0 |
| Redemptions | $612M | $435M | $360M |
| Net realized gain (non-derivative) | $583M | $215M | $423M |
| Net unrealized appreciation (non-derivative) | $-91.2M | $2.03B | $-812M |
The three months of the reporting period, as filed; month 3 ends July 31, 2026.
| Holding | Value | % of net assets |
|---|---|---|
| Eli Lilly & Co EC | $3.29B | 8.61% |
| Merck & Co Inc EC | $2.08B | 5.44% |
| Johnson & Johnson EC | $1.84B | 4.83% |
| Astrazeneca PLC EC | $1.75B | 4.59% |
| Unitedhealth Group Inc EC | $1.55B | 4.05% |
| Gsk PLC EC | $1.15B | 3.00% |
| Edwards Lifesciences Corp EC | $978M | 2.56% |
| Intuitive Surgical Inc EC | $963M | 2.52% |
| Cvs Health Corp EC | $962M | 2.52% |
| Cencora Inc EC | $945M | 2.47% |
| Vertex Pharmaceuticals Inc EC | $902M | 2.36% |
| Abbvie Inc EC | $880M | 2.30% |
| Danaher Corp EC | $834M | 2.18% |
| Regeneron Pharmaceuticals Inc EC | $818M | 2.14% |
| Novartis Ag EC | $729M | 1.91% |
| Elevance Health Inc EC | $698M | 1.83% |
| Argenx Se EC | $642M | 1.68% |
| Hca Healthcare Inc EC | $642M | 1.68% |
| Ucb Sa EC | $637M | 1.67% |
| Boston Scientific Corp EC | $583M | 1.53% |
| Agilent Technologies Inc EC | $570M | 1.49% |
| Biogen Inc EC | $557M | 1.46% |
| Galderma Group Ag EC | $525M | 1.37% |
| Roche Holding Ag EC | $450M | 1.18% |
| Dexcom Inc EC | $449M | 1.18% |
| Alnylam Pharmaceuticals Inc EC | $439M | 1.15% |
| Cardinal Health Inc EC | $438M | 1.15% |
| Abbott Laboratories EC | $393M | 1.03% |
| Shionogi & Co Ltd EC | $387M | 1.01% |
| Centene Corp EC | $383M | 1.00% |
| Amgen Inc EC | $379M | 0.99% |
| Otsuka Holdings Co Ltd EC | $376M | 0.99% |
| Revolution Medicines Inc EC | $373M | 0.98% |
| United Therapeutics Corp EC | $372M | 0.98% |
| Genmab A/s EC | $368M | 0.96% |
| Daiichi Sankyo Co Ltd EC | $366M | 0.96% |
| Medtronic PLC EC | $361M | 0.95% |
| Chugai Pharmaceutical Co Ltd EC | $359M | 0.94% |
| Stryker Corp EC | $354M | 0.93% |
| Ionis Pharmaceuticals Inc EC | $322M | 0.84% |
| Incyte Corp EC | $285M | 0.75% |
| Ascendis Pharma A/s EC | $268M | 0.70% |
| Thermo Fisher Scientific Inc EC | $264M | 0.69% |
| Madrigal Pharmaceuticals Inc EC | $263M | 0.69% |
| Cytokinetics Inc EC | $258M | 0.68% |
| Bridgebio Pharma Inc EC | $253M | 0.66% |
| Steris PLC EC | $251M | 0.66% |
| Qiagen Nv EC | $250M | 0.66% |
| Eisai Co Ltd EC | $221M | 0.58% |
| Cg Oncology Inc EC | $204M | 0.53% |
| Bristol-myers Squibb Co EC | $200M | 0.52% |
| Kymera Therapeutics Inc EC | $186M | 0.49% |
| Scholar Rock Holding Corp EC | $183M | 0.48% |
| Protagonist Therapeutics Inc EC | $170M | 0.45% |
| Dianthus Therapeutics Inc EC | $161M | 0.42% |
| Structure Therapeutics Inc EC | $157M | 0.41% |
| Novo Nordisk A/s EC | $157M | 0.41% |
| Ptc Therapeutics Inc EC | $157M | 0.41% |
| Option Care Health Inc EC | $155M | 0.41% |
| Icon PLC EC | $153M | 0.40% |
Showing top 60 of 97 holdings.
Loading...
